FTCOE White Box Study

FTCOE White Box Study

Seized Drugs Interlaboratory Comparison Study

White Box Study of 'Real World' Samples

The Forensic Technology Center of Excellence (FTCOE) funded by the National Institute of Justice (NIJ, 15PNIJ-21-GK-02192-MUMU) is conducting a research evaluation of analytical schemes used within seized drug chemistry. The purpose of this study is to evaluate the performance of different analytical schemes that follow ASTM E2329-17 Standard Practice for Identification of Seized Drugs. Your participation will help determine the efficacy of analytical schemes used by seized drug chemists.

The FTCOE is currently seeking volunteer laboratories to participate in this important study. FTCOE will ask volunteer laboratories to analyze a set of eight unknown samples consisting of controlled and non-controlled substances using analytical schemes that follow ASTM E2329-17. The participating laboratories will be asked to provide their results along with a short questionnaire about the identification and reporting process. The results will be compiled and reviewed to evaluate various analytical schemes. Results for the study will be anonymized and reported in aggregate form. Neither the participant laboratories nor their individual responses will be identified in the final report.

If your laboratory is interested in participating in this unique opportunity, please complete the following form.

The answers you provide are confidential and will only be seen by the FTCOE interlaboratory study team; we will never share your personal information or any information you give about your laboratory with any third parties. Additionally, your participation is completely voluntary and can be discontinued any time before the start of the study. Please see the Frequently Asked Questions document for additional information about the study.

If selected for the study, we will contact you to provide additional information. If you have any questions, please contact Megan Grabenauer: mgrabenauer@rti.org, (919-541-7463).

Name*

Please enter your full name below.

Contact Information*

Please enter your email address below. The FTCOE may contact you to clarify input received during the study.

Agency*

Please enter your agency/organization name below.

DEA Registration Number

Please enter your DEA registration number below.

Note: If your DEA registration number is not available when completing the form, please email the number to mgrabenauer@rti.org.

Controlled Substance Registration Certificate Upload

Please upload a scanned copy (PDF format) of your agency's DEA Controlled Substance Registration Certificate (Form DEA-223).

Note: If your agency's Form DEA-223 is not available when completing the form, please email a scanned copy to mgrabenauer@rti.org.

Drag and drop files here or

Consent Acknowledgement*

The answers you provide are confidential and will only be seen by the FTCOE interlaboratory study team. We will never share your personal information or any information you give about your laboratory with any third parties without your explicit consent. Additionally, your participation is completely voluntary and can be discontinued at any time. We will only retain and use the information provided throughout the duration of the study. We may contact you to clarify input received after receiving your results. By agreeing to participate, you agree to be contacted by FTCOE.

By checking the box, participants agree to the terms noted above. Additional information about RTI’s privacy policy can be found at https://www.rti.org/privacy-policy. Consent Acknowledgement must be checked to continue.

Comments

If you have any comments or questions, please enter them below or email Megan Grabenauer at mgrabenauer@rti.org.

Send me a copy of my responses

Privacy Notice|Report Abuse